Amgen Expands Research Network with New Indian Innovation Hub
Pharmaceutical giant Amgen is expanding its global research and development network by opening a new Science and Innovation Center at Genome Valley in Hyderabad, India. The center will join seven other research laboratories operated by the company worldwide.
The new facility reflects Amgen's focus on using biology and technology to fight diseases. By integrating scientific capabilities with data and digital innovation, the company aims to accelerate the discovery and development of medicines for patients globally.
According to Jay Bradner, M.D., executive vice president of Research and Development, Artificial Intelligence and Data at Amgen, 'The new center in Genome Valley expands the way we integrate experimental science with data and technology across our global research capabilities and complements our strong U.S.-based Research and Development footprint.'
The Science and Innovation Center is expected to be operational by 2027. It will bring together scientists and technologists from various disciplines, including discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine.